Pawel K. Mazur, Ph.D.
The University of Texas M.D. Anderson Cancer Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR160078|
Recruitment of First-Time, Tenure-Track Faculty Members
August 17, 2016
Pancreatic cancer is one of the deadliest and most aggressive cancers and is projected to surpass breast, prostate, and colorectal cancers to become the second leading cause of cancer-related deaths. Even if initially responsive to chemotherapy, pancreatic cancer almost inevitably becomes resistant to treatment.
Now a researcher at The University of Texas MD Anderson Cancer Center hopes to deprive pancreatic cancer of the cellular building blocks it relies on to supply its out-of-control growth. This may eventually lead to therapy that could demolish pancreatic cancer.